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ABSTRACT 
 
In 2012, in Europe, there were noticed over 3 
million new cases of cancer and 1.75 million of 
deaths from cancer. Numerous anticancer agents are 
cytotoxic, can damage normal cells, and they can 
cause serious side effects. Currently, natural and 
non-toxic agents are being sought that reduce the 
cost of therapy, are more effective and targeted, and 
do not damage healthy cells. Chrysin which belong 
to flavonoids family as natural substance, has 
multiple anticancer activities. It has been reported 
that chrysin can induce apoptosis in tumour cells by 
different mechanism. In our work we demonstrated 
the potential use of chrysin in gastrointestinal, 
breast, cervical, and lung cancer. In conclusion it is 
proven that chrysin or combination of chrysin with 
other related drugs can effectively improve the 
effectiveness of anticancer therapy. Furthermore, 
new agents, such as nanoparticles, may show greater 
efficacy, and better targeting, hence, less side effects 
on healthy cells. Based on these results, nanochrysin 
it offers as new and effective drug delivery system. 
Moreover, it has been reported that chrysin is a 
potential antitumor but also an adjuvant agent that 
can be used in combination with other antimetastatic 
substances to reduce tumor metastasis. 
  
Keywords: Chrysin; Flavonoids; Propolis; Anticancer 
activity. 
 
1. INTRODUCTION 
 
 Propolis, or 'bee glue', is natural sticky plant 
product created by bees which colour varies from 
yellowish-green to dark brown, depended from its 
origin and age [1-3]. Propolis can be used as a built 
material and as biological weapon because of its 
antibacterial, antifungal, antiviral, cytotoxic, anti-
oxidant, anti-inflammatory and immunomodulatory 
effects [4-9].  
 The chemical composition of propolis is 
complex and very different, as well as being 
dependent upon the geographic region, botanical 
origin and collecting bee species [1, 7, 10]. These 
factors have influence on its biological activity. In 
most European countries, propolis is collected by 
bees from black poplar, birch, alder, pine and 
willow species buds [2, 7]. Each source generates a 
different propolis. In the most common types, such 
as poplar propolis, flavones, flavanones, phenolic 
acids and their esters, predominate. In the birch 
propolis, flavones and flavonols (but not the same as 
in the poplar type) dominate. In the green propolis, 
we find mainly prenylated p-coumaric acids and 
diterpenic acids, while in red propolis, we see 
polyprenylated benzophenones [1].  
 Researchers working between 2000 and 2012, 
identified about 300 compounds in the various 
propolis, including flavonoids, terpenes, phenolics 
and their esters, lipid-wax substances, beeswax, 
sugars, hydrocarbons and mineral elements, vita-
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mins, proteins, and amino acids [2, 10]. In general, 
however, raw propolis is composed of waxes (30%), 
resins and vegetable balsam (50%), essential and 
aromatic oils (10%), pollens and other substances 
(5%) [6, 7, 9, 10].    
 The flavonoids are a major chemical com-
ponent of propolis. These flavonoids are a group of 
polyphenols with different structures and properties 
[2]. Flavonoids can be found in fruits, vegetables, 
grains, nuts, seeds, tea and herbs. In the plants, 
flavonoids are concentrated mainly in the leaves and 
flowers [11-14]. Chemically, they have structure of 
15 carbon atoms, described as C6-C3-C6, with a 
benzoic ring and a phenylopropane unit [2, 11, 14-
16]. The double band between C2 and C3 in the               
C ring influences the antioxidative activity of                
the flavonoids. This can be affected by way of 
glycolysation at position C3 [2, 11, 14, 17]. In 
accordance to the chemical structure, flavonoids 
may be classified into: flavones, flavonols, flava-
nones, flavanonols, chalcones, dihydrochalcones, 
isoflavones, isodihydroflavones, flavans,isoflavans, 
and neoflavonoids [10, 14, 16].  
 Chrysin (5,7-dihydroxyflavone or 5,7-dihy-
droxy-2-phenyl-4Hchromen-4-one) is one of the 
flavones which can be found in passion flower 
(Passifloracaerulea), in honey, in propolis and in 
bee pollen (Fig 1.) [12, 17, 18]. The chemical 
structure of chrysin, with the presence of a double 
band between C2-C3 in ring C, and the lacking of 
oxygenation at C3 (Fig 1.), is associated with 
numerous pharmacological properties. These 
include anti-microbial, anti-inflammatory, anti-
spasmodic, anxiolytic, anthelmintic, anti-cancer, 
hypoglycemic, antiatherogenic, and anti-HIV [12, 
14, 18-21].  
 
 
 
Figure 1. Structure of chrysin.  
 
 
 The effectiveness of all drugs and natural 
substances is dependent of their bioavailability and 
the solubility of these agents, but is also associated 
with their cytotoxicity [12]. Chrysin has a relatively 
low solubility and is poorly absorbed in the intestine 
which may limit its bioavailability and made it less 
useful during any therapy [22, 23]. The cytotoxicity 
of chrysin is dependent of used dosage [24].  
 In 2012, in Europe, there were noticed over           
3 million new cases of cancer and 1.75 million of 
deaths from cancer. The most common types of 
cancer and most common causes of death were: 
female breast, colorectal, prostate and lung cancers 
[25]. Cancer as a multifactorial disease, may have           
a genetic background and be caused by harmful 
environmental factors [26, 27]. Numerous anti-
cancer agents are cytotoxic, can damage normal 
cells, and they can cause serious side effects [26]. 
Currently, natural and non-toxic agents are being 
sought that reduce the cost of therapy, are more 
effective and targeted, and do not damage healthy 
cells. Flavonoids as natural substances, are regarded 
as safe and easy to obtain, so they are good 
candidates to anticancer therapy in clinical treat-
ment [13]. 
 The multiple anticancer activities of chrysin 
has drawn our attention. It has been reported that 
chrysin can induce apoptosis in different tumour 
cells [21, 26, 28-30], inhibit cell proliferation and 
block the cell cycle [31]. Moreover, it can acti-    
vate notch 1 signalling [32], and it is a histone 
deacetylase inhibitor which can significantly inhibit 
tumour growth [33]. However, Song et al. [21] 
report that the addition of amino acids reduce the 
anti-cancer activity of chrysin.  
 In this review we looked for potential 
antineoplastic action of chrysin or chrysin in 
combination with other active substances in selected 
cancer diseases. In addition, evaluating and 
investigating the pathway and mechanism of action 
of this substance on cancer cells may be of great 
importance when planning antineoplastic therapy. 
 
2. USE OF CHRYSIN IN SELECTED CANCER 
DISEASES 
 
2.1. Chrysin in gastric cancer 
  
 According to published statistics, gastro-
intestinal cancers are one of the leading causes of 
cancer deaths in the world. One of the major clinical 
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problems is the late recognition and lack of effective 
antineoplastic therapy [25, 34].  
 Chrysin and triphenylgermanium Bromide 
(Chry-Ge) induced apoptosis in Colo205 cells by 
way of the intrinsic pathway. Moreover, it led to the 
reorganization of cytoskeleton and was evidenced of 
damaging the nucleus in Colo205 cells [35]. Other 
authors have investigated the effects of chrysin on 
MMP-9 (matrix metalloproteinase-9) expression and 
activity in AGS gastric cancer cells. In such studies, 
they found that chrysin can decrease cancer 
invasiveness in cells by controlling MMP-9 
expression through the suppression of the JNK/c-
Jun and ERK/c-Fos signaling pathways [36]. 
Moreover, chrysin can suppress RON (Recepteur 
d'origine Nantais) in the AGS cells, which, as a 
consequence, decreases cell invasion [37]. The 
phenolic compounds in New Zealand propolis, as 
well as chrysin alone, showed anti-proliferative and 
anti-inflammatory assays against three gastro-
intestinal cancer cell lines; HCT-116 colon carci-
noma, KYSE-30 oesophageal squamous cancer, and 
NCI-N87 gastric carcinoma [38]. In the Leòn et al. 
[39] study, the authors investigated the mechanisms 
of action of two flavonoids:silibinin (VOsil), and 
chrysin (VOchrys) in a human colon adenocarci-
noma cell line (HT-29). Their results indicated that 
the complexation of the flavonoids inhibited the 
viability of HT-29 cells in a dose dependent manner. 
Moreover, the anticancer effects of VOchrys were 
mediated by a decrease of the GSH (glutathione) 
levels and by cell cycle arrest. 
 Chrysin treatment induced Tnfα and Tnfβ 
gene expression and activated multiple TNF-
mediated signaling pathways in Colon (HCT116, 
DLD1) and rectal (SW837) cancer cell lines leading 
to apoptosis. In addition, it has been suggested             
that this comes about by way of a novel pathway             
in which the transcriptional factor AHR (Aryl 
Hydrocarbon Receptor) is required. The cell 
viability in all cell lines was decreased at 50 μM and 
100 μM chrysin [40]. In HCT116 cells, chrysin 
induced cell death by DNA damage dependent of 
used dosage, as well as by mitochondrial membrane 
perturbation accompanied by cytochrome c release, 
down-regulation of Bcl-2, the activation of BID and 
Bax, and caspase-3 activation [41]. In related work, 
Mohammadian et al. [42] revealed that chrysin 
inhibits the growth of the AGS human gastric cell 
line. In this study, the authors used a PLGA-PEG-
chrysin complex, as well as free chrysin. Herein,  
the value of inhibitory concentration 50 (IC50)            
was calculated for each case. Their results showed 
that the IC50 value was significantly decreased              
in nanocapsulatedchrysin, in comparison with               
free chrysin. This finding directly indicated that 
capsulated chrysin is more effective than free. 
 In the Li et al. study [43], the authors 
investigated the influence of the combination of 
chrysin and cisplatin on Hep G2 cancer cells, and 
saw increased apoptosis in Hep G2 cancer cells. 
Furthermore, the combination of chrysin and 
cisplatin treatment increased the expression of 
proapoptotic proteins (p53, Bax, and DR5), while it 
decreased the expression of the antiapoptotic protein 
Bcl-2. In addition, the combination of chrysin and 
cisplatin promoted both extrinsic and intrinsic 
apoptosis pathways by activating caspase-8 and 
caspase-9 in the Hep G2 cells. Similar results were 
obtained by Zhang et al. [30] and Huang et al. [44]. 
Huang et al. [44] used chrysin combined with 
apigenin and observed that this combination can 
reduce HepG2 and MDA-MB-231 proliferation and 
cell motility, as well as induce apoptosis. 
 
2.2. Chrysin in female reproductive system 
 
 Breast cancer is the most frequently 
diagnosed cancer and the leading cause of cancer 
death among women [25, 45]. Among the cancers of 
the female reproductive system, however, cervical, 
endometrial and ovarian cancers are predominant. 
Indeed, cervical cancer is the third most common 
type among women, worldwide [46].  
 Lirdprapamongkol et al. [47] analyzed the 
effect of chrysin and tectochrysin on hypoxic 
survival of 4T1 mouse breast cancer cells in vitro. 
After application of 40-100 μM of chrysin, they saw 
a decrease in hypoxic cell survival, while the 
application of tectochrysin in a 60 μM concentration 
did not show any changes. Because tumor hypoxia 
is correlated with metastasis, the authors also 
examined the influence of chrysin on the 4T1 cell 
line, via the spontaneous lung metastasis model. 
They found out that administration of 100 and 250 
mg/kg of chrysin by day, did not show any 
significant effect on primary tumor growth, but, the 
number of metastatic colonies in the lung was 
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decreased, as was the total number of metastases, 
while the size of metastases were significant 
suppressed in a dose-dependent manner. 
 It was showed that 5,7-dihydroxy-8-nitro-
chrysin (NOC), a novel synthetic chrysin analog, 
induce apoptosis in MDA-MB-453 human breast 
cancer cell line intrinsically, via activation of 
caspase-9. In the tested cells, apoptosis were 
induced by activation of the Akt/FOXO3a axis 
(Forkhead box O3a transcription factor), with 
increased Bim (B cell lymphoma 2 (Bcl-2) - 
aninteracting mediator of cell death) expression 
[48]. Similar results were seen in a 2014 follow-up 
study. Herein, the authors reported that LW-214             
(a new flavonoid sourced from chrysin), activated 
the intrinsic mitochondrial apoptotic pathway in 
human breast cancer MCF-7 cells. However, after 
24 h, decreased expression of Bcl-2 and increased 
expression of Bax was observed, in a dose-
dependent manner [49]. Zhao et al. [48] also used a 
nude mice model bearing an inoculated MCF-7 
tumor to determine the influence of LW-214 in 
vivo. In this experiment, they saw that LW-214 
inhibited tumor growth. In H&E staining, noted no 
morphological changes observed in the organs, and 
no significant difference was seen in the average 
body weight of mice treated by LW-214, compared 
with a control group. In conclusion, it suggest that 
LW-214 has anticancer effects in the MCF-7 cell 
line in vivo and in vitro [48, 49]. 
 Another type of a new chrysin analog, 
8-bromo-7-methoxychrysin (BrMC), induced intrin-
sic apoptosis in a time-dependent manner, via the 
Akt/FOXO3a axis in cisplatin (DDP)-sensitive 
(A2780) and -resistant (A2780/DDP) ovarian cancer 
cell lines. The effect of BrMCis greater that natural 
chrysin [50]. 
 Mohammadinejad et al. [51], on a T47D 
breast cancer cell line, examined the effect of 
encapsulated chrysin in PLGA-PEG (poly (D, L-
lactic-co-glycolic acid) and poly (ethylene glycol) as 
compared to pure chrysin. They saw that loaded 
chrysin in PLGA-PEG increases its solubility and 
tolerance, and decreases the side effects of the drug. 
In addition, the authors observed that pure chrysin 
and chrysin nanoparticles inhibited cell proliferation 
in a dose dependent manner. As a result of such, 
they suggested that placing the chrysin into 
nanoparticles improves its effectiveness on cell 
growth inhibition, and it strongly decreases the 
cyclin D1 expression. This study was continued by 
Eatemadi et al. [52] and Anari et al. [53]. Anari et 
al. [53] evaluated the cytotoxicity of chrysin 
nanoparticles and pure chrysin on two human breast 
cancer cell lines: T47D and MCF7. They confirmed 
the results of Mohammadinejad et al. [51] in that 
nanochrysin has a positive effect on the breast 
cancer cell lines (T47D and MCF7) in a dose-
dependent and time-dependent manner. Still, they 
noted that the MCF7 cell line is less sensitive to 
chrysin than is the line T47D. Eatemadi et al. [52] 
have also shown that nanochrysin has a time-
dependent cytotoxic effect, plus they found that it 
increased the expression of the BRCA1 gene and 
reduced the expression of the hTERT and FTO 
genes in the T47D cell line. By the way, chrysin 
inhibited the migration and invasion of MDA-MB-
231 and BT-549 cell lines by way of the down-
regulation of MMP-10 (matrix metalloproteinase-
10). In both lines, MDA-MB-231 and BT-549, 
chrysin treatment increased the expression of E-
cadherin, while it decreased the expression of 
vimentin, snail and slug. This suggests that chrysin 
has a reversal effect on the epithelial-mesenchymal 
transition [54]. 
 Co-treatment therapy with chrysin and 
1,2,3,4,6-penta-O-galloyl-b-D-glucose (5GG) indu-
ced apoptosis, cell cycle arrest, inhibited cell 
proliferation and colony formation in AU565 and 
MDA-MB-231 human breast cancer cells. The 
combination of chrysin and 5GG decreased the 
growth of tumor by down-regulation of the 
phospho-LRP6 (pLRP6) and Skp2 proteins [55]. 
Another combination of chrysin, chrysin and 
apigenin reduced cell viability and cell motility, as 
well as induced apoptosis in a dose- and time- 
dependent manner in MDA-MB-231 breast cancer 
cell line. Herein, co-treatment for 36 h syner-
gistically decreased cell line motility but not 
viability, but significant cytotoxicity was observed 
for 72 h of co-treatment [44]. 
 In another work, the authors examined the 
anticancer activity of S. discolor (Scutellaria 
discolor Colebr., SDE) on different cancer cell lines, 
and they isolated the substance which is responsible 
for this action. They discovered that SDE induced 
cell death in a concentration dependent-manner by 
up-regulation of APAF1, BAX, BCL2L11, caspase 
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9, DFFA, GADD45A and TP53, and increased the 
expression of caspase-3mRNA. In their work, they 
saw that the stronger effects were observed in                
the cervical cancer cell line, HeLa. This result               
was confirmed by utilizing the lines ME180                  
and Bu25TK. In addition, spectroscopic methods 
indicated that chrysin was the major compound              
of SDE that had showed the antiproliferative 
activity [56]. 
 
2.3. Chrysin in respiratory system 
 
 According to data, lung cancer is one of the 
leading causes of cancer death in developed 
countries [25, 57]. 
 Shao et al. [58] reported that chrysin induces 
growth inhibition and apoptosis in the A549 
cultured lung cancer cells. They also put forward 
that the actuation of AMP-activated protein kinase 
(AMPK) may have contributed to this process, as 
their Western-blot analysis results demonstrated a 
significant AMPK activation after chrysin treatment 
in A549 cells. Moreover, inhibition of AMPK by 
shRNA-mediated gene silencing, or by its inhibitor, 
diminished chrysin-induced A549 cell growth 
inhibition and apoptosis. Furthermore, forced 
activation of AMPK by introducing a constitutively 
active form of AMPKa (CA-AMPKa), or by its 
activators, mimicked the chrysin effect. In addition, 
as they found that chrysin inhibited the 
Akt/mammalian target of rapamycin (mTOR) 
activation, knocking down of AMPK by shRNA 
almost reversed this effect. Finally, they observed 
that a relative low dose of chrysin enhanced 
doxorubicin-induced AMPK activation, hence 
promoting A549 cell apoptosis. 
 Kasala et al. [59] investigated the chemo-
preventive role of chrysin against benzo(a)pyrene 
[B(a)P] induced lung carcinogenesis in Swiss albino 
mice. In their work, they administered B(a)P orally 
(50 mg/kg body weight) twice a week for four 
weeks to induce lung cancer in the test mice. They 
reported that administration of B(a)P resulted in 
increased lipid peroxides and carcinoembryonic 
antigens, with concomitant decrease in the levels of 
both enzymatic and non-enzymatic antioxidants. 
Chrysin supplementation down-regulated the 
expression of PCNA, COX-2 and NF-kB and 
maintained cellular homeostasis. This confirmed the 
chemopreventive potential of chrysin against B(a)P 
induced lung cancer in Swiss albino mice [59]. 
In A549 cells, in vitro, Lim et al. [60] 
investigated the combination of chrysin and 
docetaxel (DTX). As a result of this study, they saw 
increased cytotoxicity, suppressed cellular 
proliferation and induced apoptosis in the post-
treatment of chrysin following prior DTX treatment. 
Moreover, in vivo, chrysin enhanced the tumor 
growth delay activity of DTX and increased DTX-
induced apoptosis by way of the A549-derived 
xenograft model. Furthermore, chrysin prevented 
DTX-induced edema in ICR mouse-subjects.           
These results indicate that chrysin administration 
strengthened the therapeutic efficacy of DTX and 
diminished the adverse effect of DTX. This outcome 
suggests that chrysin could be exploited as an 
adjuvant therapy for NSCLC. 
 Brechbuhlf et al. [61] reported that treatment 
with chrysin resulted in significant and sustained 
intracellular flavonoid-induced glutathione (GSH) 
depletion. What is more, the GSH enzyme network 
in the four cancer cell types was predictive of the 
severity of chrysin-induced intracellular GSH 
depletion. Their gene expression data also indicated 
a positive correlation between basal MRP1, MRP3 
and MRP5 expression, and total GSH efflux before 
and after chrysin exposure. In addition, Brechbuhlf 
et al. [61] saw that in all the four investigated cell 
lines, co-treating the cells for 72 hours with chrysin 
(5-30 μM) and doxorubicin (DOX) (0.025-3.0 μM) 
significantly enhanced the sensitivity of the cells               
to DOX, as compared to 72-hour DOX alone 
treatment. In this experiment, the maximum 
decrease in the IC50 values of cells treated with 
DOX alone compared to co-treatment with chrysin 
and DOX was 43% in A549 cells, 47% in H157 and 
H1975 cells and 78% in H460 cells. Hence, chrysin 
worked synergistically with DOX to induce cancer 
cell death. This approach could allow for use of 
lower concentrations of applied chemo-therapy 
agents, by sensitizing cancer cells that are typically 
resistant to therapy to such agents. 
 Moreover, propolis extract and chrysin 
sensitizes A549 human lung adenocarcinoma and 
HeLa human cancer cell lines to TRAIL-induced 
apoptosis. Moreover, the TRAIL sensitization effect 
of chrysin is not mediated by inhibition of TRAIL-
induced NF-κB activation or by glutathione 
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depletion. In actuality, immunoblot analysis using a 
panel of anti-apoptotic proteins, revealed that 
chrysin selectively decreases the levels of Mcl-1 
protein, by down-regulating Mcl-1 gene expression 
as determined by qRT-PCR. The contribution of 
Mcl-1 in TRAIL resistance was confirmed by si-
Mcl-1 knockdown. Indeed, among the signaling 
pathways that regulate Mcl-1 gene expression, only 
that constitutive of STAT3 phosphorylation was 
suppressed by chrysin. The proposed action of 
chrysin in TRAIL sensitization by inhibiting STAT3 
and down-regulating Mcl-1 was supported by using 
a STAT3-specific inhibitor, cucurbitacin-I, which 
decreased Mcl-1 levels and enhanced TRAIL-
induced cell death, in a manner similar to that 
observed with chrysin treatment [62]. 
 Narayan and Kumar [63] explored the 
antineoplastic and immunomodulatory effects of 
chrysin (derived from an extract of Achyranthes 
aspera) (PCA) on urethane-induced lung cancer in 
vivo. In the study, PCA was fed orally to urethane 
(ethyl carbamate) primed lung cancerous mice at               
a dosage of 100 mg/kg body weight for 30 
consecutive days. Herein, the enhanced activity             
and expression of the antioxidant enzymes GST, 
GR, CAT, SOD, as well as down-regulation of 
expression and activation of LDH enzymes in PCA 
were observed. What is more, PCA fed urethane-
primed lung tissues showed down-regulated expres-
sion of the pro-inflammatory cytokines IL-1b, IL-6 
and TNF, along with that of TFs, NF-jB and Stat3, 
while the expression of the proapoptotic proteins 
Bax and p53 was enhanced. In related experimental 
work, FTIR and CD spectroscopy data revealed that 
PCA resisted the urethane mediated conformational 
changes of DNA. This was made evident by the 
shift in guanine and thymine bands in FTIR, from 
1,708 to 1,711 cm-1 and 1,675 to 1,671 cm-1, 
respectively. The present study suggests that PCA 
components have a synergistic anti-cancerous and 
cytokine based immunomodulatory roll. Moreover, 
they have DNA conformation restoring effects. 
 
 
Table 1. The type of active substances and the cell line on which they act. 
Substances Cell lines of the digestive system  
Chrysin  
 
Chrysin and triphenylgermanium Bromide (Chry-Ge)  
Silibinin (VOsil) 
PLGA-PEG-chrysin complex  
Chrysin and cisplatin combination 
Chrysin and apigenin combination 
Colo205, AGS, HCT-116, KYSE-30, NCI-N87, HT-29, 
DLD1, SW837 
Colo205 
HT-29 
AGS 
HepG2 
HepG2 
Substances Cell lines of the female reproductive system  
Chrysin 
Chrysin and apigenin combination 
5,7-dihydroxy-8-nitrochrysin (NOC) (synthetic chrysin 
analog) 
LW-214 (flavonoid sourced from chrysin) 
8-bromo-7-methoxychrysin (BrMC) (chrysin analog) 
PLGA-PEG-chrysin complex 
Chrysin and 1,2,3,4,6-penta-O-galloyl-b-D-glucose (5GG) 
Scutellaria discolor Colebr., SDE* 
4T1, T47D, MCF7, MDA-MB-231, BT-549 
MDA-MB-231 
MDA-MB-453 
MCF-7 
A2780, A2780/DDP 
T47D, MCF7 
MDA-MB-231, AU565 
HeLa, ME180, Bu25TK 
Substances Cell lines of the respiratory system  
Chrysin 
 
 
Chrysin and docetaxel combination  
Chrysin and doxorubicin combination 
A549, lung cancer in Swiss albino mice induced by 
benzo(a)pyrene [B(a)P], urethane-induced lung cancer              
in vivo 
A549 
A549, H157, H1975, H460 
*Chrysin is a major compound of SDE with antiproliferative activity 
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3. CONCLUSION 
  
 The mechanism of action of chrysin is based 
on the induction of apoptosis in tumor cells, 
whereas in the initiation of this process various 
proteins and enzymes may be involved i.a.Bax, Bcl-
2, caspases: 3, 8 and 9, p53 protein, and cytochrome 
C. In addition, chrysin exhibits an anti-inflammatory 
and anti-proliferative effects, it inhibited cancer 
cells growth and also reduces viability and motility 
of various tumor cells. Numerous studies have 
shown that the use of chrysin, chrysin analogues or 
chrysin combinations and other related drugs can 
effectively improve the effectiveness of anticancer 
therapy (Table 1.). Furthermore, new agents, such as 
nanoparticles, may show greater efficacy, and better 
targeting, hence, less side effects on healthy cells 
(Table 1.). Based on these results, nanochrysin 
offers new and effective drug delivery system. 
Moreover, it has been reported that chrysin is a 
potential antitumor but also an adjuvant agent that 
can be used in combination with other antimetastatic 
substances to reduce tumor metastasis.  
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